Companies / Myriad Genetics Inc
Myriad Genetics Inc
Financials · FY2025
Ownership
95.6M shares outstanding · as of Jul 28, 2026
Ownership
| Insiders | 4.57% | 4,373,782 |
| 10%+ / strategic | 5.21% | 4,985,060 |
| Institutions | 219.59% | 210,033,350 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Raha Samraat S.CEOPresident and CEO · Director | 1.11% | 1,064,541 |
Verratti MarkChief Operating Officer | 0.66% | 630,715 |
Donnelly Brian JChief Commerical Officer | 0.65% | 624,338 |
Muzzey DaleChief Scientific Officer | 0.34% | 327,256 |
Fox Jennifer LynneChief Legal Officer | 0.32% | 310,362 |
Wheeler Benjamin RichardChief Financial Officer | 0.31% | 298,509 |
Phanstiel S. LouiseDirector | 0.29% | 281,951 |
Solaiman ShereenChief People Officer | 0.28% | 267,801 |
Dreismann HeinrichDirector | 0.24% | 231,145 |
Haas Kevin RichardChief Technology Officer | 0.19% | 180,022 |
Institutional holders 228
View all →| Holder | Value | % of shares |
|---|---|---|
| $122.88M | 130.69% | |
| $62.18M | 11.39% | |
| $50.59M | 8.60% | |
| $30.01M | 6.97% | |
| $28.46M | 5.21% | |
| $24.35M | 5.66% | |
| $22.19M | 3.77% | |
| $20.25M | 4.70% | |
| $13.96M | 2.37% | |
| $13.29M | 2.26% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Phanstiel S. Louise Director | Buy | Common Stock | $242.1K | +50K +27.46% | 233,951 0.24% of shares | medium |
| Feb 27, 2026 | Phanstiel S. Louise Director | Buy | Common Stock | $223.7K | +48K +20.52% | 281,951 0.29% of shares | medium |
| Mar 9, 2026 | Raha Samraat S. CEO | Buy | Common Stock | $199.8K | +40K +8.83% | 493,104 0.52% of shares | medium |
| Mar 13, 2026 | Raha Samraat S. CEO | Other | Common Stock | $169.2K | -36K -3.27% | 1,075,357 1.12% of shares | low |
| Mar 13, 2026 | Muzzey Dale Executive | Other | Common Stock | $59.6K | -13K -3.48% | 354,295 0.37% of shares | low |
| Mar 15, 2026 | Muzzey Dale Executive | Other | Common Stock | $55.7K | -12K -3.50% | 329,275 0.34% of shares | low |
| Mar 14, 2026 | Raha Samraat S. CEO | Other | Common Stock | $50.4K | -11K -1.01% | 1,064,541 1.11% of shares | low |
| Mar 13, 2026 | Verratti Mark Executive | Other | Common Stock | $42.7K | -9K -1.38% | 652,895 0.68% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Glenview Capital Management, LLC | Passive13G | — |
| Integrated Core Strategies (US) LLC | Passive13G/A | — |
| State Street Corporation | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MYGN | — | 62855J104 |